Global Pulmonary Function Testing Market
The global pulmonary function testing market is expected to reach USD 5.87 billion by 2031 from USD 3.66 billion in 2023, growing at a CAGR of 6.1% in the forecast period of 2024 to 2031.
Global Pulmonary Function Testing Market, By Type (Hardware, Software, and Services), Patient Type (Adult, Geriatric, and Pediatric), Application (Obstructive Lung Disease and Restrictive Lung Disease), End User (Hospital, Specialty Clinics, Diagnostics Laboratories, Home Care Settings, and Others), Countries (U.S., Canada, Mexico, Germany, Italy, U.K., France, Switzerland, Spain, Russia, Turkey, Belgium, Netherlands, Sweden, Denmark, Norway, Finland, Poland, rest of Europe, China, India, South Korea, Japan, Thailand, Australia, Singapore, Indonesia, Taiwan, New Zealand, Vietnam, Malaysia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, U.A.E., South Africa, Qatar, Kuwait, Oman, Bahrain, Egypt, Israel and rest of Middle East and Africa) - Industry Trends and Forecast to 2031
Overview of Global Pulmonary Function Testing Market Dynamics:Driver
• Increasing prevalence of respiratory diseases
Restraint
• High cost of testing equipment
Opportunity
• Rapid technological advancements
Market Players:
The key players operating in the global pulmonary function testing market are:
• VYAIRE MEDICAL, INC.
• Teleflex Incorporated
• CAIRE, Inc.
• COSMED srl
• Schiller AG
• Ganshorn Medizin Electronic GmbH
• PULMONE ADVANCED MEDICAL DEVICE
• ndd Medical Technologies
• KoKo PFT
• GERATHERM MEDICAL AG
• ECO MEDICS
• Morgan Scientific
• Inofab Health
• SIBEL, S.A.U.
• Clarity Medical
• Data Sciences International
• IngMar Medical
• JK Medical System Pvt. Ltd
• MEC
• Scireq
• MEDLINE
• Recorders and Medicare Systems
• VITALOGRAPH
• medical equipment europe GMBH
• CHEST M.I., Inc.
• CONTEC MEDICAL SYSTEMS CO., LTD
• FUKUDA SANGYO CO., LTD.